
ZBB2397 Breakthrough Longevity & Anti-Aging Supplement Company – Patent-Backed IP
Extreme Longevity & Anti-Aging (ELA) is an innovation-driven supplement and health tech company focused on reversing aging and preventing chronic disease Backed by over a decade of scientific research and human testing, ELA has developed 14 proprietary, patent-pending formulas targeting biological systems and chronic illnesses including cancer, Parkinson’s, diabetes, heart disease, and more With exclusive formulations, no competitors offering similar mapped-to-system solutions, and 11 patents in progress through Knobbe Martens, this is a rare opportunity to own one of the most disruptive wellness technologies available today.
Ideal for strategic buyers in the nutraceutical, pharmaceutical, or biotech space.
Highlights:.
- 14 proprietary, evidence-based formulas mapped to human biological systems.
- 3 patents pending; 11 additional patent applications underway.
- No lease, low fixed overhead, high scalability potential.
- Fully trademarked brand with .
com, .
net, and .
org domains secured.
- Over 350 nutrients tested through live human trials.
- Products address major conditions: cancer, diabetes, Parkinson’s, PCOS, and more.
- Legal IP managed by top-tier law firm Knobbe Martens.
- Gender-specific and condition-specific delivery formats (capsules, powders, liquids).
Don’t miss your chance to own a first-mover in the next wave of health and longevity innovation.